Fair point made in your last sentence. That will of course come...

First 30389 Last

Share
Profile

Follow
adpadp

147 Posts.

14

09/05/22

16:34

Post #: 61294231
Share

Originally posted by mondyinvest: ↑

Yes, I was looking into this after the 4C. It is a bit confusing at first look but Settlement date was 30 November 2021. The 1 December 2021 announcement said that the condition precedents had been satisfied and that "the first tranche of its investment in IDSB can now be completed ("Settlement"). The payment was $20.7M, and was made the day before, on 30 November (which is reflected in the mid-March 2022 announcement update - it's the paragraph immediately below the one you screenshotted). The payment made it into the 31 December 2021 cashflow statement 4C. Also, the half-yearly reports IOU's 21% holding for the month of December only, as that was the first month of ownership.

For reasons unknown the IDSB accounts still haven't been audited. I had wondered that with an IOUpay individual now on the IDSB board it might be in IOU's interest for the auditing to keep getting pushed out (to save them having to make the tranche 2 payment in an uncertain cash position) as the language is unclear: "being the later of the completion of the audit of IDSB's FY21 statutory accounts or six months after settlement". In theory you could interpret this to mean that if the auditing isn't done after 30 May 2022, tranche 2 still won't be due. After all, if the accounts aren't audited, how can IOU determine the amount they still need to pay?

Expand

Fair point made in your last sentence. That will of course come at the expense of sacrificing our share of the extra 21% of dividends

IOU Price at posting: 8.6¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

PL3

Patagonia looks to raise $2.15M for South American exploration and development

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

There are more pages in this discussion • 1,933 more messages in this thread...

First 30389 Last

Add OVT (ASX) to my watchlist

(20min delay)
Last 0.8¢		Change -0.001(11.1%)		Mkt cap ! $9.920M

Open	High	Low	Value	Volume
1.0¢	1.0¢	0.8¢	$95.87K	11.68M

Buyers (Bids)

No.	Vol.	Price($)
4	1162531	0.8¢

Sellers (Offers)

Price($)	Vol.	No.
0.9¢	2258000	9

View Market Depth

No.	Vol.	Price($)
4	1162531	0.008
23	4906113	0.007
16	8404229	0.006
13	4758100	0.005
5	1536128	0.004

Price($)	Vol.	No.
0.009	2258000	9
0.010	2767681	10
0.011	1250367	4
0.012	1914130	8
0.013	561417	3

Last trade - 16.10pm 09/07/2024 (20 minute delay)

OVT (ASX) Chart

Fair point made in your last sentence. That will of course come...

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Patagonia looks to raise $2.15M for South American exploration and development

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Fair point made in your last sentence. That will of course come...

Top Stories

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Patagonia looks to raise $2.15M for South American exploration and development

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News